Health Care·Health Care Equipment·$6.0B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $3.51 | N/A | +15.96% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $3.51 | N/A | +15.96% |
| Revenue | N/A | N/A | N/A |
Tone: Defensive
Management acknowledged the impact of external factors on performance. They are prioritizing stability and efficiency in operations.
Management highlighted ongoing challenges in the supply chain.
They emphasized a focus on cost management and operational efficiency.
Teleflex's strong EPS performance indicates better-than-expected profitability, but the stock fell by 5.16%. This decline may reflect investor concerns about ongoing supply chain challenges and the lack of revenue details. Without updated guidance, investors may remain cautious about future growth prospects.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
KIMBERLY CLARK CORP
Oct 25, 2021